EcoDrugPlus

Membrane Metalloendopeptidase

Ensembl ID : ENSONIG00000003515
Gene Symbol: MME
3 Cross references
233 Possible Orthologues:

Metabotropic Glutamate Receptor 2

Ensembl ID : ENSONIG00000004117
Gene Symbol: LOC100708712
4 Cross references
206 Possible Orthologues:

Metabotropic Glutamate Receptor 3

Ensembl ID : ENSONIG00000014984
Gene Symbol: LOC100706095
4 Cross references
215 Possible Orthologues:

Methionyl Aminopeptidase 2b

Ensembl ID : ENSONIG00000017841
Gene Symbol: METAP2B
1 Cross references
220 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSONIG00000031950
Gene Symbol: MAPK1
3 Cross references
209 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSONIG00000019408
Gene Symbol: LOC100697722
3 Cross references
197 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSONIG00000007660
Gene Symbol: MAPK10
3 Cross references
88 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSONIG00000009933
Gene Symbol: LOC100700904
4 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSONIG00000019351
Gene Symbol: MAPK14
4 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSONIG00000011834
Gene Symbol: MAPK14
3 Cross references
206 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSONIG00000019745
Gene Symbol: LOC100702235
3 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 8a

Ensembl ID : ENSONIG00000009562
Gene Symbol: MAPK8A
1 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).